Cormedix
CRMD
$5.31
Share price
2.31%
Change (1 day)
13.46%
Change (1 year)
Categories
Market capitalization of Cormedix (CRMD)
Market cap: $0.29 Billion
As of April 2024 Cormedix has a market cap of $0.29 Billion. This makes Cormedix the world's 6563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cormedix from 2010 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.29 B | 41.66% |
| 2023 | $0.20 B | 18.3% |
| 2022 | $0.17 B | 0.53% |
| 2021 | $0.17 B | -27.41% |
| 2020 | $0.23 B | 27.78% |
| 2019 | $0.18 B | 33.03% |
| 2018 | $0.14 B | 317.42% |
| 2017 | $33.64 M | -45.6% |
| 2016 | $61.85 M | -15.28% |
| 2015 | $73 M | 70.17% |
| 2014 | $42.9 M | 108.34% |
| 2013 | $20.59 M | 150.63% |
| 2012 | $8.21 M | 155.03% |
| 2011 | $3.22 M | -84.48% |
| 2010 | $20.76 M |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of Cormedix was reported to be:
$0.29 Billion
$0.28 Billion
$0.28 Billion
$0.28 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | $66.89 B | 22,813.29% | 🇺🇸 USA |
 Utah Medical Products UTMD | $0.23 B | -18.96% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.10 B | -65.55% | 🇺🇸 USA |